Countermeasures against Counterfeit Medicines

Patient safety is greatly threatened in developing countries, where 10-30% of the drugs in circulation are reported to be counterfeit.

JPMA collaborates with various stakeholders and implements the following initiatives.

JPMA regularly conducts a survey on counterfeit medicines among member companies to grasp the actual state of anti-counterfeiting efforts at member companies.